News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen Class of 2024
Insights
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Jobs
Career Advice
Companies
Hotbeds
More
Employer Resources
Best Places to Work
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen Class of 2024
Insights
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Jobs
Career Advice
Companies
Hotbeds
More
Employer Resources
Best Places to Work
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
683,521 Results
Type
Article (40061)
Company Profile (271)
Press Release (643189)
Section
Business (204798)
Career Advice (2005)
Deals (35466)
Drug Delivery (80)
Drug Development (80911)
Employer Resources (167)
FDA (16059)
Job Trends (14846)
News (345447)
Policy (32552)
Tag
Academia (2578)
Africa (718)
Alliances (49390)
Alzheimer's disease (1156)
Approvals (15983)
Arizona (174)
Artificial intelligence (69)
Asia (37069)
Australia (6045)
Bankruptcy (352)
Best Places to Work (11309)
Biosimilars (63)
Biotechnology (193)
C2C Services and Suppliers (79088)
California (1884)
Canada (931)
Cancer (486)
Career advice (1673)
Cell therapy (120)
China (151)
Clinical research (63388)
Collaboration (140)
Colorado (76)
Compensation (81)
Connecticut (73)
COVID-19 (2510)
Cystic fibrosis (73)
Data (312)
Diabetes (82)
Diagnostics (5996)
Drug pricing (65)
Earnings (83772)
Employer resources (142)
Europe (79257)
Events (108385)
Executive appointments (150)
FDA (16285)
Florida (262)
Funding (147)
Gene therapy (91)
GLP-1 (514)
Government (4311)
Healthcare (18671)
Hotbed/Location (483206)
Illinois (257)
Indiana (146)
Infectious disease (2537)
Inflammatory bowel disease (93)
Interviews (308)
IPO (16237)
Job creations (3658)
Job search strategy (1437)
Kansas (95)
Layoffs (398)
Legal (7877)
Lung cancer (110)
Manufacturing (85)
Maryland (394)
Massachusetts (1527)
Medical device (13064)
Medtech (13069)
Mergers & acquisitions (19094)
Metabolic disorders (247)
Michigan (124)
Minnesota (214)
Neuroscience (1302)
New Jersey (575)
New York (592)
NextGen Class of 2024 (6532)
Non-profit (4481)
North Carolina (588)
Northern California (825)
Obesity (145)
Ohio (106)
Opinion (175)
Patents (70)
Pennsylvania (581)
People (56396)
Pharmaceutical (63)
Phase I (19658)
Phase II (27912)
Phase III (20849)
Pipeline (111)
Postmarket research (2561)
Preclinical (8377)
Press Release (64)
Rare diseases (129)
Real estate (5933)
Recruiting (63)
Regulatory (21275)
Research institute (2326)
Resumes & cover letters (347)
South America (1092)
Southern California (762)
Startups (3634)
Texas (241)
United States (8554)
Vaccines (475)
Washington State (254)
Weight loss (127)
Date
Today (117)
Last 7 days (674)
Last 30 days (2412)
Last 365 days (37347)
2024 (26223)
2023 (40217)
2022 (51344)
2021 (55889)
2020 (54224)
2019 (46727)
2018 (35183)
2017 (32287)
2016 (31707)
2015 (37796)
2014 (31539)
2013 (26631)
2012 (28894)
2011 (29539)
2010 (27634)
683,521 Results for "harvard bioscience inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Genetown
Harvard Bioscience, Inc. to Present at the Jefferies Global Healthcare Conference on June 5, 2024
Harvard Bioscience, Inc. announced that Jim Green, Chairman and Chief Executive Officer, and Jennifer Cote, Chief Financial Officer, will be presenting to investors at the Jefferies Global Healthcare Conference at the Marriott Marquis in New York City on June 5, 2024.
May 23, 2024
·
1 min read
Genetown
Harvard Bioscience, Inc. to Participate in the Benchmark Healthcare House Call Virtual Conference
Harvard Bioscience, Inc. (Nasdaq: HBIO) today announced that Jim Green, Chairman and Chief Executive Officer, and Jennifer Cote, Chief Financial Officer, will be participating in the Benchmark Healthcare House Call Virtual Conference on May 22nd, 2024, with a live fireside chat scheduled for 9:00-9:40 am ET.
May 16, 2024
·
1 min read
Business
Harvard Bioscience, Inc. to Participate in the Sidoti Small Cap Virtual Conference
September 5, 2024
·
1 min read
Genetown
Harvard Bioscience, Inc. to Present and Host One-on-One Meetings at the 14th Annual East Coast IDEAS Conference on June 12, 2024
Harvard Bioscience, Inc. (Nasdaq: HBIO) today announced that Jim Green, Chairman and Chief Executive Officer, and Jennifer Cote, Chief Financial Officer, will be presenting to investors at the 14th Annual East Coast IDEAS Conference at the Jay Conference Center – Bryant Park in New York City on June 12, 2024.
June 6, 2024
·
1 min read
Business
Harvard Bioscience Announces First Quarter 2024 Financial ResultsStrong gross margin performance and focus on efficiency to support ongoing investments in growth
Harvard Bioscience, Inc. announced financial results for the first quarter ended March 31, 2024.
May 7, 2024
·
10 min read
Genetown
Harvard Bioscience Announces Action to Improve Operational Efficiency and Support Ongoing Investments in Growth
Harvard Bioscience, Inc. announced a labor force reduction to improve its operating cost structure and support its ongoing investments in growth.
April 9, 2024
·
2 min read
Business
Harvard Bioscience Announces Fourth Quarter 2023 Financial Results
Harvard Bioscience, Inc. today announced financial results for the fourth quarter and year ended December 31, 2023.
March 7, 2024
·
13 min read
Genetown
Harvard Bioscience, Inc. to Participate in March 2024 Investor Conferences: Sidoti’s Small Cap Conference and KeyBanc’s Life Sciences & MedTech Conference
Harvard Bioscience, Inc. (Nasdaq: HBIO) today announced that Jim Green, Chairman and Chief Executive Officer, will be presenting to investors at the upcoming Sidoti Small Cap Conference and KeyBanc Life Sciences & MedTech Conference, both to be held virtually in March 2024.
March 11, 2024
·
1 min read
Business
Harvard Bioscience Schedules First Quarter 2024 Earnings Conference Call for May 7, 2024 at 8:00 AM ET
Harvard Bioscience, Inc. (Nasdaq: HBIO) will announce its financial results for the quarter ended March 31, 2024 before the market opens on May 7, 2024, and will hold a conference call to discuss the results at 8:00 a.m. Eastern Time.
April 29, 2024
·
1 min read
Genetown
Harvard Bioscience to Showcase Latest Solutions for Preclinical and Organoid Applications at Society of Toxicology Meeting
Harvard Bioscience, Inc. (Nasdaq: HBIO) today announced that it will be showcasing its latest product innovations at the Society of Toxicology (SOT) conference from March 11-13, 2024, in Salt Lake City.
March 6, 2024
·
5 min read
1 of 68,353
Next
